Anesthesia, Local
Conditions
Keywords
lidocaine, mandible
Brief summary
Assess the clinical impact of Buffered 1% lidocaine with epinephrine as compared to the Non-buffered 1% lidocaine with epinephrine in dental and oral surgical procedures.
Detailed description
Background: Based on the discovery of its topical and locally injected anesthetic effects at the end of the 19th century, cocaine was rapidly adopted as a means of blocking painful sensory impulses from the periphery during surgical procedures.(1) In the last decade local anesthetics have been administered more often, alone or in combination with IV or inhalation anesthetics for most surgical procedures. For clinical procedures in the head and neck the local anesthetic drugs have been combined with a vasoconstrictor, usually epinephrine, to prolong the anesthetic effect at the locally injected anatomic site. To achieve pulpal and periosteal anesthesia by nerve or field block for procedures in dentistry, lidocaine at a 2% concentration has been preferred by clinicians for its reliable outcomes. To prolong the shelf life of the vasopressor, the drug combination must be formulated with a low pH, approximately pH 3.5 for lidocaine with 1/100k epinephrine (Epi). With a better understanding of the pharmacology, new options for improving local anesthetic effectiveness including buffering the commercially supplied drugs to a neutral pH just prior to injection, continue to emerge.(2) When injected, the low pH causes the sting felt by patients on injection. Buffering to a neutral pH eliminates this discomfort and makes the maximum concentration of the non-ionized form of the anesthetic drug immediately available to the targeted nerve membrane.(3-7) Until recently, buffering local anesthetics containing Epi followed with bicarbonate just prior to injection was impractical for the quantities used in intraoral procedures. However, today we do have options to efficiently accomplish this buffering technique.(Anutra Medical, Research TrianglePark, NC). Buffering local anesthetics just prior to use produces positive outcomes including less sting on injection, faster onset of the drug, and possibly added drug potency, ie the same positive clinical effect at lower dosage. In pilot studies with healthy adults as their own controls investigators have shown that Buffered 1% lidocaine with 1/100k Epi was as effective as Non-buffered 2% lidocaine with 1/100k Epi for pulpal anesthesia on a 1st molar or canine after nerve block in the mandible or field block in the maxilla-Phase one of this study.(8,9) These outcomes could be beneficial for performing multiple procedures in children whose lidocaine dosage is limited by body weight or others with chronic liver disease. Rationale: The recently reported results from the two clinical studies involving buffered lidocaine with Epi have led to clinicians questioning whether the Buffered 1% lidocaine with Epi might be as effective for achieving pulpal and periosteal anesthesia for dental procedures as Non-Buffered 1% lidocaine with Epi-Phase two of this study, outcomes not usually considered by most clinicians. This protocol addresses that question. Specific Aims: Compare clinical depths of pulpal anesthesia for maxillary(Phase one) and mandibular(Phase two) molar and canine teeth at 30min intervals Post-injection of lidocaine Assess pain levels during injection Assess time after injection to lower lip numb Hypotheses: No differences exist in anesthetic depth for pulpal anesthesia after intraoral injection mandibular nerve block between Buffered 1% lidocaine with 1/100k epinephrine as compared to Non-buffered 1% lidocaine with 1/100k epinephrine. Subjects will serve as their own controls in a cross-over AB/BA study design which is uniform within sequences, uniform within periods, and balanced
Interventions
Efficacy for mandibular molar and canine anesthesia
Sponsors
Study design
Masking description
double blind
Eligibility
Inclusion criteria
Age 18-30 years American Society Anesthesiologists I,II
Exclusion criteria
Allergy to lidocaine class of anesthetic drugs Local anesthetic drug use in past week Current symptoms in teeth or oral mucosa
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Time to Pulpal Response After Mandibular Molar Anesthesia | Every 30 minutes up to 120 minutes Total | Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no |
| Mean Time to Pulpal Response After Mandibular Canine Anesthesia | 30 minute intervals up to 120 minutes | Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| All Study Participants Participants who were to receive either Buffered 1% lidocaine or Non-Buffered 2% Lidocaine | 24 |
| Total | 24 |
Baseline characteristics
| Characteristic | All Study Participants |
|---|---|
| Age, Categorical <=18 years | 0 Participants |
| Age, Categorical >=65 years | 0 Participants |
| Age, Categorical Between 18 and 65 years | 24 Participants |
| Age, Continuous | 24 years |
| Ethnicity (NIH/OMB) Hispanic or Latino | 2 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 21 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants |
| Region of Enrollment United States | 24 Participants |
| Sex: Female, Male Female | 13 Participants |
| Sex: Female, Male Male | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 24 | 0 / 24 |
| other Total, other adverse events | 0 / 24 | 0 / 24 |
| serious Total, serious adverse events | 0 / 24 | 0 / 24 |
Outcome results
Mean Time to Pulpal Response After Mandibular Canine Anesthesia
Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no
Time frame: 30 minute intervals up to 120 minutes
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine | Mean Time to Pulpal Response After Mandibular Canine Anesthesia | 81.3 minutes | Standard Deviation 44.7 |
| Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine | Mean Time to Pulpal Response After Mandibular Canine Anesthesia | 97.5 minutes | Standard Deviation 43.6 |
Mean Time to Pulpal Response After Mandibular Molar Anesthesia
Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no
Time frame: Every 30 minutes up to 120 minutes Total
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Buffered 1% Lidocaine, Then Non-Buffered 1% Lidocaine | Mean Time to Pulpal Response After Mandibular Molar Anesthesia | 100 minutes | Standard Deviation 37.2 |
| Non-buffered 1% Lididocaine, the Buffered 1% Lidocaine | Mean Time to Pulpal Response After Mandibular Molar Anesthesia | 106 minutes | Standard Deviation 41.5 |